Other congenital hydrocephalus in Italy: Symptoms, Causes & Treatment | aihealz
ICD variantOther congenital hydrocephalus is a specific ICD-10 coded subtype of Hydrocephalus. The clinical content below covers Hydrocephalus in general.
GeneticsmoderateICD-10 · Q03.8
Other congenital hydrocephalus.Care & specialists in Italy
In Italy, other congenital hydrocephalus is managed by geneticss. Hydrocephalus is an abnormal accumulation of cerebrospinal fluid (CSF) inside the brain's ventricular system, raising intracranial pressure or distorting brain tissue when CSF production exceeds absorption or when flow is obstructed. Roughly 1 in 770 newborns is affected globally, and an estimated 700,000 American adults live with idiopathic normal pressure hydrocephalus, the most common adult form.
aliases · Hydrocephalus (water on the brain)· Water on the brain· Hydrocéphalie· Hidrocefalia· reviewed May 14, 2026
EB
Reviewed by AIHealz Medical Editorial Board · GeneticsLast reviewed May 13, 2026
Hydrocephalus (ICD-10: G91 in adults, Q03 in congenital, G91.2 idiopathic normal pressure) is a heterogeneous group of disorders defined by progressive ventricular enlargement secondary to imbalance between cerebrospinal fluid production at the choroid plexus (about 500 mL/day in adults) and absorption at the arachnoid villi and lymphatic pathways. The Rekate classification divides hydrocephalus by the site of CSF flow obstruction: foramen of Monro, aqueduct of Sylvius, fourth ventricle outflow, basal cisterns, or arachnoid villi. The historic dichotomy of communicating versus non-communicating (obstructive) hydrocephalus remains useful clinically; obstructive hydrocephalus causes acute deterioration and requires urgent CSF diversion, while communicating hydrocephalus, including idiopathic normal pressure hydrocephalus, develops gradually with the classic triad of gait apraxia, cognitive impairment, and urinary incontinence (Hakim's triad). Etiologies include congenital aqueductal stenosis, Chiari malformations, neural tube defects, intraventricular hemorrhage of prematurity, post-meningitic adhesions, tumors blocking CSF pathways, subarachnoid hemorrhage, and idiopathic processes.
key facts
Prevalence
Congenital hydrocephalus: 1 in 770 live births globally (Isaacs PLoS One 2018); idiopathic normal pressure hydrocephalus: 0.2-2.9% of adults over 65 (Jaraj et al. Neurology 2014)
Demographics
Bimodal age distribution: infants under 2 years and adults over 60. Slight male predominance in congenital cases (1.3:1). All ethnicities affected; folate fortification reduces neural tube defect–related cases
Avg. age
Congenital and infantile: presentation in first year of life; idiopathic normal pressure hydrocephalus: typical onset age 65-80
Global cases
§ 02
How you might notice it
The key symptoms of Other congenital hydrocephalus are: Rapidly enlarging head with abnormal head-circumference crossing two percentile lines in an infant under 18 months, often with widely separated cranial sutures and a tense bulging anterior fontanelle., Persistent downward deviation of both eyes (the 'setting-sun' sign) caused by pressure on the dorsal midbrain in infants and young children with obstructive hydrocephalus., Morning headache that improves on standing, often with projectile vomiting and progressively worsens over weeks in children and adults with raised intracranial pressure., Magnetic, broad-based, shuffling gait with reduced step height and difficulty initiating walking — the most common and earliest symptom of idiopathic normal pressure hydrocephalus in 90% of patients., Subcortical cognitive impairment with bradyphrenia, executive dysfunction, apathy, and impaired attention in adult-onset hydrocephalus, distinguishable from cortical dementia by relatively preserved memory storage., Urinary urgency progressing to frank incontinence in 60-80% of patients with iNPH, often preceded by detrusor overactivity demonstrable on urodynamic study., Papilledema on fundoscopy with blurring of disc margins, venous engorgement, and eventually optic atrophy and vision loss when intracranial pressure has been elevated for weeks..
01Rapidly enlarging head with abnormal head-circumference crossing two percentile lines in an infant under 18 months, often with widely separated cranial sutures and a tense bulging anterior fontanelle.
02Persistent downward deviation of both eyes (the 'setting-sun' sign) caused by pressure on the dorsal midbrain in infants and young children with obstructive hydrocephalus.
03Morning headache that improves on standing, often with projectile vomiting and progressively worsens over weeks in children and adults with raised intracranial pressure.
§ 03
How it’s diagnosed
diagnosis
Diagnosis combines clinical examination, neuroimaging, and selected CSF testing. In infants, serial head-circumference measurement on World Health Organization growth charts identifies the rapidly enlarging head; cranial ultrasound through the open fontanelle is the first-line imaging study and detects ventricular dilation and intraventricular hemorrhage without sedation. In older children and adults, MRI brain with thin-cut sagittal sequences through the aqueduct is the diagnostic standard — it confirms ventricular enlargement, identifies obstruction (tumor, aqueductal stenosis), assesses CSF flow with phase-contrast cine sequences, and rules out hydrocephalus ex vacuo by demonstrating disproportionate ventricular size relative to cortical atrophy. The Evans index (ratio of frontal horn width to maximum biparietal diameter) above 0.30 supports ventriculomegaly; a callosal angle below 90° on coronal MRI distinguishes iNPH from atrophic ventriculomegaly with 93% specificity. CT brain is faster and useful for shunt-malfunction assessment and acute presentations but exposes children to radiation. In suspected iNPH, a high-volume lumbar tap test (drainage of 40-50 mL of CSF) with timed gait and cognitive testing before and after carries sensitivity of about 60% and specificity above 80% for predicting shunt response; extended lumbar drainage over 72 hours raises sensitivity to 90%. Intracranial-pressure monitoring or CSF infusion studies are reserved for ambiguous cases at high-volume centers. Funduscopy for papilledema, visual-evoked potentials, and neuropsychological assessment complete the workup.
Key tests
01
MRI brain with cine phase-contrast CSF flowGold-standard imaging — confirms ventricular dilation, identifies obstruction at the aqueduct, demonstrates CSF flow void, and distinguishes hydrocephalus from atrophy
02
Cranial ultrasound through the anterior fontanelleFirst-line bedside imaging in infants under 18 months to detect ventricular dilation, intraventricular hemorrhage, and periventricular leukomalacia
§ 04
Treatment & cost
medical treatments
✓Acetazolamide (25 mg/kg/day in infants; 250-1,000 mg/day in adults)
✓Intraventricular antibiotics (vancomycin or gentamicin)
surgical options
Ventriculoperitoneal (VP) shunt with programmable valveSymptom control in 85-90% initially; revision-free survival 65-70% at 2 years, 50-55% at 5 years
Endoscopic third ventriculostomy (ETV)1-year ETV success: 70-85% in aqueductal stenosis, 50-65% in post-hemorrhagic disease; predicted by the ETV Success Score
ETV with choroid plexus cauterization5-year shunt-free survival 60-70% in infants under 1 year, comparable to shunt in this population (Warf series J Neurosurg Pediatr 2005)
Ventriculoatrial or ventriculopleural shuntComparable initial efficacy to VP shunt; higher rates of cardiac and pulmonary complications over decades
§ 05
Causes & risk factors
known causes
Congenital aqueductal stenosis
Narrowing of the cerebral aqueduct of Sylvius is the single most common cause of fetal and infantile obstructive hydrocephalus, accounting for about 30% of congenital cases. X-linked forms caused by L1CAM mutations affect males. Antenatal ultrasound at 18-22 weeks identifies most cases.
Neural tube defects and Chiari II malformation
Approximately 80% of children with myelomeningocele develop hydrocephalus from Chiari II malformation with downward displacement of the cerebellum and obstruction of fourth ventricle outflow. Folate fortification has cut the incidence of neural-tube defects by 25-50% in fortified countries.
Intraventricular hemorrhage of prematurity
Germinal matrix hemorrhage in preterm infants under 32 weeks gestation obstructs CSF pathways with blood products and inflammation. Grade III-IV intraventricular hemorrhage progresses to post-hemorrhagic hydrocephalus in 25-50% of cases.
Brain tumors blocking CSF flow
Posterior fossa tumors (medulloblastoma, ependymoma, pilocytic astrocytoma) in children and pineal region or colloid cysts in adults compress the aqueduct or fourth ventricle. Sudden death from acute obstruction is well-documented with colloid cysts of the third ventricle.
Bacterial or tuberculous meningitis
Post-meningitic adhesions in the basal cisterns and arachnoid villi reduce CSF absorption. Tuberculous meningitis causes hydrocephalus in 50-80% of cases, often within 4-6 weeks of infection. Bacterial meningitis in neonates is a major cause of acquired hydrocephalus in low-income settings.
Subarachnoid hemorrhage
Aneurysmal subarachnoid hemorrhage causes acute communicating hydrocephalus in 15-20% of cases (within 72 hours) and chronic shunt-dependent hydrocephalus in 10-30% from arachnoid scarring. Blood breakdown products obstruct absorption at the arachnoid villi.
§ 06
Living with it
01Periconceptional folic acid 400 µg daily for all women planning pregnancy, raised to 4 mg in those with a previous neural-tube defect — reduces incidence by 50-70%.
02Antenatal corticosteroids and delayed cord clamping in threatened preterm delivery to reduce intraventricular hemorrhage by 25-40%.
03Routine BCG vaccination, prompt treatment of suspected tuberculous meningitis with dexamethasone, and antibiotic prophylaxis after neurosurgery to prevent post-infectious hydrocephalus.
04Helmet use in cycling, motorcycling, and contact sports to reduce traumatic intraventricular hemorrhage.
05Antenatal ultrasound screening at 18-22 weeks gestation to identify fetal ventriculomegaly and plan delivery at a center with pediatric neurosurgery.
06Fetal surgical repair of myelomeningocele between 19 and 26 weeks where available, which reduces the shunt-rate from 82% to 40% (MOMS trial, NEJM 2011).
recommended foods
•Folate-rich foods (leafy greens, beans, lentils, fortified cereals) before and during pregnancy
§ 07
When to seek help
why see a genetics
Pediatric or adult neurosurgery is mandatory once hydrocephalus is suspected on imaging — the decision between VP shunt, ETV, ETV plus choroid plexus cauterization, and observation depends on age, etiology, ventricular anatomy, and ETV Success Score. Neurology, neuropsychology, and rehabilitation evaluate and document the cognitive, gait, and continence deficits before and after surgery. Ophthalmology monitors papilledema and protects vision while CSF diversion is planned.
01Shunt obstruction or fracture — most common cause of revision; presents with morning headache, vomiting, and lethargy. Plain shunt-series radiographs and CT detect most cases.
02Shunt infection (5-10% in 30 days) caused mostly by coagulase-negative staphylococci; managed by hardware removal, external ventricular drainage, and 10-21 days of antibiotics.
03Over-drainage with chronic subdural hematoma in 5-15% of adults, treated by raising the valve setting or surgical drainage.
04Slit-ventricle syndrome in children with chronic over-drainage — disabling intermittent headache that responds to anti-siphon valves.
05Seizures in 5-10% of shunted patients, particularly after cortical trajectory or after meningitis.
Congenital hydrocephalusPresent at birth or detected antenatally on ultrasound. Most cases stem from aqueductal stenosis (about one-third), neural tube defects with Chiari II malformation, Dandy-Walker malformation, or X-linked L1CAM mutations. Often associated with macrocephaly, splayed sutures, and the 'setting-sun' sign of forced downward gaze.
Acquired (obstructive) hydrocephalusDevelops after birth due to intraventricular hemorrhage, meningitis, tumors of the posterior fossa or pineal region, cysticercosis, or trauma blocking CSF flow at the aqueduct or fourth ventricle outlets. Onset is over days to weeks with rising intracranial pressure.
Communicating hydrocephalusCSF reaches the subarachnoid space but is poorly reabsorbed, most often after subarachnoid hemorrhage, meningitis, leptomeningeal carcinomatosis, or chronic inflammation. All four ventricles enlarge symmetrically.
Idiopathic normal pressure hydrocephalus (iNPH)Adult-onset triad of magnetic gait, mild cognitive impairment, and urinary urgency or incontinence in a patient with disproportionate ventriculomegaly and a callosal angle below 90°. CSF pressure measured at lumbar puncture is normal but pulsatility and resistance to outflow are abnormal.
Post-hemorrhagic hydrocephalus of prematurityAffects 15-25% of preterm infants under 1,500 g after grade III-IV intraventricular hemorrhage. Subependymal germinal matrix bleeding obstructs CSF pathways or reduces absorption, often requiring serial taps, reservoir placement, or eventual shunt.
Hydrocephalus ex vacuoApparent ventricular enlargement caused by atrophy of surrounding brain tissue rather than true CSF imbalance. Common in advanced age, severe traumatic brain injury, and neurodegenerative disease. Does not benefit from CSF diversion and is the most common pitfall in iNPH diagnosis.
Living with Other congenital hydrocephalus
Timeline
Postoperative hospital stay 2-5 days for uncomplicated shunt and 1-3 days for ETV. Headache and incision tenderness fade over 1-2 weeks. Gait improvement in iNPH is often noticeable within days and continues for 3-6 months. Cognitive and continence gains plateau at 6-12 months. Children resume schooling within 2 weeks. Annual follow-up imaging and valve checks continue lifelong.
Lifestyle
01Carry a written summary of the shunt model, valve setting, and surgeon contact at all times.
02Recognize the early signs of shunt malfunction (morning headache, vomiting, drowsiness) and seek emergency assessment.
03Avoid contact sports and head trauma when a shunt is in place; consult neurosurgery before scuba diving.
04Maintain hydration to reduce postural headaches if the valve is set to low pressure.
05Attend annual ophthalmology review for papilledema and visual fields even if asymptomatic.
06Inform any clinician of the implant before MRI; programmable valves require post-MRI setting verification.
Daily management
01Palpate the valve and shunt tubing weekly; report new tenderness, redness, or fluid tracking
02
Complementary approaches
Serial lumbar punctures or ventricular tapsUsed as a temporizing measure in preterm infants with post-hemorrhagic ventricular dilation while assessing whether definitive surgery will be needed. Each tap removes 10-15 mL/kg of CSF. Replaced by ventricular access devices in most modern neonatal units.
Subgaleal shunt or ventricular reservoirTemporary CSF diversion in low-birth-weight preterm infants too small for permanent shunting. The Cochrane 2019 ELVIS trial supported early intervention at moderate ventricular dilation.
Choosing a doctor
Choose a neurosurgeon at a high-volume center performing at least 50 shunt or ETV procedures per year, ideally affiliated with the Hydrocephalus Clinical Research Network or an equivalent national registry. For iNPH, an neurosurgery program with a structured outpatient pathway (clinical screening, tap test, extended drainage, programmable-valve shunt) outperforms ad hoc referrals. Pediatric cases benefit from a multidisciplinary clinic combining neurosurgery, neonatology, and developmental pediatrics.
Patient support resources
Hydrocephalus Association →US patient and family organization providing education, support groups, research funding, and a national HA Network of Centers of Excellence.
NHS Hydrocephalus — England →Plain-language UK National Health Service resource covering diagnosis, surgery, and recovery.
§ 08
Frequently asked
What is hydrocephalus in simple terms?▾▴
Hydrocephalus is a buildup of cerebrospinal fluid inside the brain's ventricles that raises pressure or stretches brain tissue. It occurs when fluid cannot drain or be reabsorbed normally. Treatment is surgical, using either a shunt or an endoscopic third ventriculostomy to redirect the fluid.
How do you know if a baby has hydrocephalus?▾▴
Warning signs include a head circumference growing faster than the body, a tense or bulging fontanelle, splaying of the skull sutures, downward deviation of the eyes (setting-sun sign), poor feeding, and irritability. Cranial ultrasound through the fontanelle confirms ventricular enlargement quickly and without sedation.
What are the symptoms of normal pressure hydrocephalus in adults?▾▴
The classic triad is gait disturbance (magnetic, wide-based walking), cognitive slowing, and urinary urgency or incontinence. Symptoms develop over months, often misdiagnosed as Alzheimer's or Parkinson's. MRI shows disproportionate ventricular enlargement and a callosal angle below 90 degrees.
Can hydrocephalus be cured?▾▴
Hydrocephalus is managed rather than cured. Surgery (shunt or endoscopic third ventriculostomy) restores normal pressure and resolves symptoms in 70-90% of patients. Lifelong follow-up is needed because shunts can obstruct, infect, or over-drain. Children may need repeated revisions during growth.
What is a ventriculoperitoneal shunt?▾▴
A VP shunt is a thin silicone tube that drains cerebrospinal fluid from a brain ventricle through a programmable valve under the skin into the abdominal cavity. It is the most common surgery for hydrocephalus. Modern shunts allow non-invasive pressure adjustment using an external magnet.
What is endoscopic third ventriculostomy?▾▴
Endoscopic third ventriculostomy (ETV) is a keyhole operation creating a small opening in the floor of the third ventricle so cerebrospinal fluid bypasses an obstruction. ETV avoids permanent hardware and works best in aqueductal stenosis. The Kulkarni success score predicts 6-month outcomes.
How long does a shunt last?▾▴
About 40% of shunts need revision within 5 years, most often for obstruction, infection, or over-drainage. Infections occur in 5-10% of placements within 30 days. Many shunts function 10-20 years; lifelong monitoring with periodic imaging and ophthalmology review is recommended.
What are the signs of shunt failure?▾▴
Common signs include new morning headache, vomiting, drowsiness, irritability, double vision, return of original symptoms, and bulging fontanelle in infants. Any of these requires urgent imaging — untreated shunt obstruction can progress to coma and herniation within hours.
Is hydrocephalus genetic?▾▴
Approximately 5-10% of congenital cases have an identifiable genetic cause, most commonly L1CAM mutations on the X chromosome affecting boys. Family history of hydrocephalus, neural-tube defects, or unexplained infant deaths warrants genetic counseling and antenatal ultrasound screening.
Can folic acid prevent hydrocephalus?▾▴
Folic acid 400 micrograms daily before conception reduces neural-tube defects by 50-70%. Because 80% of spina bifida cases develop hydrocephalus, folate fortification prevents thousands of cases annually. Women planning pregnancy should start folic acid at least three months before conception.
Does hydrocephalus cause learning problems?▾▴
Children with treated hydrocephalus have average IQ within the normal range in 60-75% of cases. Common difficulties include reduced processing speed, visual-spatial skills, and executive function. Early surgery, control of seizures, and educational support improve long-term outcomes.
How is normal pressure hydrocephalus diagnosed?▾▴
Diagnosis combines the clinical triad (gait, cognition, continence), MRI showing disproportionate ventricular enlargement with a callosal angle below 90 degrees, and a positive response to a high-volume lumbar tap test or 72-hour extended lumbar drainage. Phase-contrast CSF flow studies support the diagnosis.
Can adults develop hydrocephalus suddenly?▾▴
Yes. Acute obstructive hydrocephalus develops over hours to days from subarachnoid hemorrhage, posterior-fossa tumor, colloid cyst, or shunt malfunction. Sudden severe headache, vomiting, drowsiness, or coma needs emergency CT brain. Untreated acute obstruction can cause death within hours.
Is MRI safe with a shunt valve?▾▴
Modern programmable shunt valves are MRI conditional at 1.5 and 3 Tesla. The magnetic field can change the valve setting, so neurosurgery should reconfirm and reset the valve immediately after every MRI. Always tell the radiographer about the shunt model before scanning.
What is hydrocephalus ex vacuo?▾▴
Hydrocephalus ex vacuo describes ventricular enlargement caused by brain atrophy rather than true CSF imbalance. It appears in normal aging, advanced dementia, and severe traumatic brain injury. There is no obstruction, intracranial pressure is normal, and shunting does not help.
Can hydrocephalus return after treatment?▾▴
Symptoms can recur if a shunt obstructs, infects, or over-drains, or if an endoscopic third ventriculostomy closes — about 20-40% of ETVs fail within 2 years. Recurrence after successful surgery is otherwise uncommon if the underlying cause has been addressed. Regular follow-up imaging catches problems early.
How is hydrocephalus diagnosed before birth?▾▴
Antenatal ultrasound at 18-22 weeks gestation measures the lateral ventricle atrium; values over 10 mm signal ventriculomegaly. Fetal MRI clarifies the cause and excludes structural malformations. Confirmed cases are referred to maternal-fetal medicine and pediatric neurosurgery for delivery planning.
What is the survival rate with hydrocephalus?▾▴
Children with treated non-syndromic hydrocephalus reach adulthood in over 95% of cases in high-income countries. Untreated obstructive hydrocephalus carries 50-70% mortality within two years. Outcomes in low-resource settings remain poor because of limited neurosurgical access and shunt-revision capacity.
Does hydrocephalus cause dementia?▾▴
Idiopathic normal pressure hydrocephalus produces a subcortical dementia with slowed thinking, impaired attention, and executive dysfunction in 30-60% of patients. Up to 80% of these cases are improved by VP shunting if treated within 2 years of symptom onset. It is one of the few partially reversible dementias.
What is the difference between hydrocephalus and idiopathic intracranial hypertension?▾▴
Hydrocephalus causes ventricular enlargement on imaging; idiopathic intracranial hypertension (pseudotumor cerebri) raises CSF pressure without dilated ventricles. Both produce headache and papilledema, but treatment differs — hydrocephalus is surgical and IIH is managed with weight loss and acetazolamide.
Can children with shunts play sports?▾▴
Children with stable shunts can take part in most sports including swimming, running, cycling, and team sports. Contact sports with risk of head impact (American football, rugby, boxing) are generally avoided; helmet use is mandatory for cycling and skiing. Neurosurgery clearance is reasonable before competitive contact play.
Estimated 400,000 new pediatric cases annually worldwide; nearly 80% in low- and middle-income countries with limited neurosurgical capacity (Dewan et al. J Neurosurg 2018)
Specialist
Genetics
ICD-10
Q03.8
04Magnetic, broad-based, shuffling gait with reduced step height and difficulty initiating walking — the most common and earliest symptom of idiopathic normal pressure hydrocephalus in 90% of patients.
05Subcortical cognitive impairment with bradyphrenia, executive dysfunction, apathy, and impaired attention in adult-onset hydrocephalus, distinguishable from cortical dementia by relatively preserved memory storage.
06Urinary urgency progressing to frank incontinence in 60-80% of patients with iNPH, often preceded by detrusor overactivity demonstrable on urodynamic study.
07Papilledema on fundoscopy with blurring of disc margins, venous engorgement, and eventually optic atrophy and vision loss when intracranial pressure has been elevated for weeks.
08New-onset diplopia from sixth-nerve palsy as a non-localizing sign of raised intracranial pressure, often the first symptom that prompts neurology referral.
09Cognitive regression, irritability, declining school performance, or new ataxia in children with previously stable shunted hydrocephalus — a red flag for shunt malfunction.
10Macrocephaly with prominent scalp veins, frontal bossing, and a 'cracked-pot' resonant note on cranial percussion (Macewen's sign) in chronic infantile hydrocephalus.
early warning signs
•Head circumference crossing percentile lines on serial well-baby measurements, especially when associated with a tense fontanelle
•New-onset, daily morning headache that improves through the day in a child or adult, particularly with nausea or vomiting
•Subtle change in gait — wider stance, slower turn, 'feet stuck to the floor' description — in an older adult initially attributed to aging
•Decline in school grades, slowed thinking, or new apathy in a child with a previously placed shunt
•Loss of upgaze, intermittent diplopia, or transient visual blurring with postural change — possible early papilledema
● emergency signs
•Sudden severe headache with vomiting, declining alertness, and bradycardia in a shunted patient — likely acute shunt obstruction with impending herniation; requires emergency neurosurgical assessment
•Coma, fixed dilated pupil, decerebrate posturing, or Cushing's triad (hypertension, bradycardia, irregular respiration) — herniation in progress
•New seizure or focal neurological deficit in a patient with known hydrocephalus or recent shunt surgery
•Fever, neck stiffness, photophobia, and altered mental status in a shunted patient — possible ventriculitis or shunt infection
•Acute vision loss or rapidly worsening papilledema — pre-perimetric optic-nerve damage progresses within days
03
CT brain without contrastRapid assessment of ventricular size in emergency presentations, shunt malfunction, and acute obstruction
04
High-volume lumbar tap test (CSF drainage 40-50 mL)Predicts shunt response in suspected idiopathic normal pressure hydrocephalus
05
Extended lumbar drainage over 72 hoursHigher-sensitivity confirmation of CSF responsiveness in iNPH when tap test is equivocal
06
Intracranial pressure monitoringDocuments B-waves and abnormal pressure pulsatility in equivocal iNPH and chronic hydrocephalus
07
Phase-contrast MRI CSF flow quantification at the aqueductMeasures CSF stroke volume; values above 42 µL per cycle suggest hyperdynamic flow seen in iNPH
08
Funduscopy and optical coherence tomography (OCT)Detects papilledema and quantifies retinal nerve fiber layer thickening as objective evidence of raised intracranial pressure
Outlook
Outlook varies sharply by etiology, age, and treatment access. Children with non-syndromic aqueductal stenosis treated with ETV or shunt have 5-year survival above 95% and normal or near-normal cognition in 60-75% when surgery occurs before significant cortical thinning. Premature infants with post-hemorrhagic hydrocephalus have a less favorable course — 30-50% reach adulthood with developmental delay, and shunt revision rates exceed 40% within five years. Adult iNPH treated with programmable VP shunting improves gait in 60-80% at 12 months in selected responders, with stable benefit at 3 years in roughly half. Untreated obstructive hydrocephalus carries a mortality of 50-70% within two years of presentation in low-resource settings. Shunt-related complications dominate long-term outcomes: about 40% of patients need at least one revision in five years, infection occurs in 5-10% of operations, and over-drainage produces chronic subdural collections in 5-15%. Tumor-related hydrocephalus follows the prognosis of the underlying neoplasm.
Idiopathic processes (iNPH)
Adult-onset idiopathic normal pressure hydrocephalus has no identified cause in 50-60% of patients but associates with vascular risk factors and impaired CSF pulsatility. Glymphatic dysfunction and arachnoid granulation aging are leading hypotheses.
risk factors
Preterm birth under 32 weeksnon-modifiable
Germinal matrix hemorrhage occurs in 15-25% of infants under 1,500 g birth weight. Antenatal corticosteroids and delayed cord clamping reduce intraventricular hemorrhage incidence by 25-40%.
Maternal folate deficiency in pregnancymodifiable
Inadequate periconceptional folate intake increases neural-tube defect risk 3-4 fold. Daily 400 µg folic acid before conception reduces risk by 50-70% and is recommended by the CDC, WHO, and most national guidelines.
Family history of congenital hydrocephalusgenetic
X-linked hydrocephalus from L1CAM mutations affects approximately 1 in 30,000 male births. Autosomal recessive forms account for another 5-10% of congenital cases.
Bacterial or tuberculous meningitisenvironmental
Post-meningitic hydrocephalus occurs in 30-50% of neonatal Gram-negative meningitis and 50-80% of tuberculous meningitis cases, particularly in regions without prompt diagnosis and treatment.
Subarachnoid or intraventricular hemorrhagenon-modifiable
Aneurysmal subarachnoid hemorrhage causes shunt-dependent hydrocephalus in 10-30% of survivors. Hunt and Hess grade 4-5 carries the highest risk.
Age over 65non-modifiable
Prevalence of idiopathic normal pressure hydrocephalus rises from 0.2% at age 65 to nearly 3% by age 80 (Jaraj et al. Neurology 2014).
Cardiovascular comorbidity increases iNPH prevalence 1.5-2 fold and reduces postoperative response, possibly through coexisting subcortical small-vessel disease that mimics or contributes to symptoms.
Posterior fossa or pineal tumorsnon-modifiable
Medulloblastoma, ependymoma, and pineal region tumors obstruct CSF flow. Approximately 70-90% of children with posterior fossa tumors present with hydrocephalus.
•
Adequate hydration (1.5-2 L/day in adults) to maintain CSF homeostasis after shunting
•Balanced protein intake during recovery to support wound healing
•DASH or Mediterranean dietary pattern to control vascular risk in adults with iNPH
foods to avoid
•Alcohol excess, especially in shunted patients prone to falls and head injury
•Excessive salt intake in iNPH patients with coexistent hypertension
•Unsupervised dehydration through extreme heat or endurance exercise immediately after shunt surgery
•Vitamin A in supraphysiologic doses, which can raise intracranial pressure
06
Cognitive impairment, gait disorder, and incontinence persisting despite CSF diversion when treatment is delayed beyond 2 years from symptom onset in iNPH.
choosing the right hospital
01Pediatric or adult neurosurgery with intraoperative neuroendoscopy and image guidance
02MRI scanner with phase-contrast CSF flow sequences
03Neurointensive care for postoperative monitoring
04Antibiotic-impregnated shunt hardware on formulary
05Dedicated iNPH outpatient pathway with tap test and extended drainage
06Ophthalmology with optical coherence tomography for papilledema follow-up
07Rehabilitation and neuropsychology for postoperative recovery
08Participation in Hydrocephalus Clinical Research Network or equivalent registry
Essential facilities
Tertiary pediatric neurosurgery centersAdult neurosurgical units with iNPH programsNeonatal intensive care units with bedside cranial ultrasoundOutpatient neurology and neuropsychology servicesOphthalmology with neuro-ophthalmology subspecialty
Compare →
Keep an updated card noting valve type, pressure setting, and date of last revision
03Use a daily symptom diary in the first year after shunt insertion or ETV
04Hydrate steadily through the day to limit postural headache from over-drainage
05Take prescribed antiseizure medication if epilepsy has co-developed
06Attend scheduled neurosurgical, neurology, and ophthalmology follow-up at 3, 6, and 12 months and annually thereafter
Exercise
Low-impact aerobic exercise (walking, stationary cycling, swimming in supervised pools) is encouraged within 4-6 weeks of uncomplicated shunt or ETV. Resistance training resumes at 6-8 weeks. Avoid contact sports (rugby, boxing, martial arts) and activities with high deceleration (downhill skiing, diving from height) in shunted patients. In iNPH, structured gait rehabilitation begins within days of CSF tap or shunt insertion and continues for at least 12 weeks.